11. P163 Tiotropium decreases the risk of exacerbations in patients with symptomatic asthma regardless of baseline characteristics including markers of allergic status. (14th November 2013) Authors: Halpin, DMG; Bateman, ED; Tashkin, DP; Engel, M; Dahl, R; Paggiaro, P; Beck, E; Vandewalker, M; Seibold, W; Moroni-Zentgraf, P; Schmidt, H; Kerstjens, HAM Journal: Thorax Issue: Volume 68(2013)Supplement 3 Page Start: A149 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. P169 Tiotropium is effective in patients with severe asthma without evidence of chronic obstructive pulmonary disease. (14th November 2013) Authors: Halpin, Dmg; Bateman, Ed; Moroni-Zentgraf, P; Engel, M; Schmidt, H; Kerstjens, Ham Journal: Thorax Issue: Volume 68(2013)Supplement 3 Page Start: A152 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. P172 Safety profile of tiotropium add-on therapy in paediatric patients by gender. (December 2018) Authors: Vogelberg, C; Engel, M; Vulcu, SD; Hamelmann, E Journal: Thorax Issue: Volume 73(2018)Supplement 4 Page Start: A195 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. P229 Once-daily Tiotropium Respimat® As Add-on To At Least Medium- To High-dose Ics, With Or Without Laba, Improves Lung Function In Patients With Symptomatic Asthma, Independent Of Allergic Status. (10th November 2014) Authors: Dahl, R; Casale, T; Pizzichini, E; Vandewalker, M; Virchow, JC; Engel, M; Sigmund, R; Moroni-Zentgraf, P; Kerstjens, HAM Journal: Thorax Issue: Volume 69(2014)Supplement 2 Page Start: A177 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. P230 Once-daily Tiotropium Respimat® Improves Lung Function In Patients With Severe Symptomatic Asthma Independent Of Leukotriene Modifier Use. (10th November 2014) Authors: Dahl, R; Doherty, DE; Corren, J; Karpel, J; Kerstjens, HAM; Engel, M; Moroni-Zentgraf, P; Schmidt, H; Hashimoto, S Journal: Thorax Issue: Volume 69(2014)Supplement 2 Page Start: A178 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. P231 Once-daily Tiotropium Respimat®: Safety And Tolerability Results From Five Phase Iii Trials In Adults With Symptomatic Asthma. (10th November 2014) Authors: Haughney, J; Vandewalker, M; Meltzer, E; Paggiaro, P; Engel, M; Unseld, A; Moroni-Zentgraf, P; Kerstjens, HAM Journal: Thorax Issue: Volume 69(2014)Supplement 2 Page Start: A178 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. P255 Once-daily Tiotropium Respimat® Add-on To At Least Ics Maintenance Therapy Reduces Exacerbation Risk In Patients With Uncontrolled Symptomatic Asthma. (10th November 2014) Authors: Halpin, DMG; Paggiaro, P; Bleecker, E; Engel, M; Moroni-Zentgraf, P; Schmidt, H; Kerstjens, HAM Journal: Thorax Issue: Volume 69(2014)Supplement 2 Page Start: A189 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. P260 Tiotropium Respimat® Add-on To Inhaled Corticosteroids Improves Lung Function In Patients With Symptomatic Mild Asthma: Results From A Phase Iii Trial. (10th November 2014) Authors: Paggiaro, P; Halpin, DMG; Buhl, R; Engel, M; Zubek, VB; Blahova, Z; Moroni-Zentgraf, P; Pizzichini, E Journal: Thorax Issue: Volume 69(2014)Supplement 2 Page Start: A191 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. P45 Effect of tiotropium respimat® on seasonal asthma worsening in paediatric patients. (December 2018) Authors: Goldstein, S; Graham, L; Vogelberg, C; Engel, M; Zaremba-Pechmann, L; Hamelmann, E Journal: Thorax Issue: Volume 73(2018)Supplement 4 Page Start: A122 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. P86 In vitro and clinical characterisation of the antistatic valved holding chamber aerochamber plus® flow-vu® for administrating tiotropium respimat® in 1–5-year-old children with persistent asthmatic symptoms. (15th November 2017) Authors: Wachtel, H; Nagel, M; Engel, M; Azzi, G El; Sharma, A; Suggett, J Journal: Thorax Issue: Volume 72(2017)Supplement 3 Page Start: A129 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗